Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.05 - $153.6 $498 - $1.53 Million
9,960 Added 41.44%
33,994 $7,000
Q2 2022

Aug 15, 2022

BUY
$100.8 - $345.6 $2.42 Million - $8.31 Million
24,034 New
24,034 $21,000
Q4 2021

Feb 14, 2022

SELL
$300.0 - $1228.8 $3.37 Million - $13.8 Million
-11,228 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$696.0 - $3477.6 $7.81 Million - $39 Million
11,228 New
11,228 $34,000

Others Institutions Holding ENSC

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0

About Ensysce Biosciences, Inc.


  • Ticker ENSC
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,918,900
  • Market Cap $1.25M
  • Description
  • Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...
More about ENSC
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.